Delivery Order SPE2DB22D1002-SPE2DB25FLFA4
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $42,011.63. This firm fixed-price delivery order, which is set to be completed by August 5, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement within the Defense Logistics Agency's medical supply...
- The Defense Logistics Agency awarded a $23,523.84 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injectable medication. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of June 3, 2025, and represents a single delivery order under AmerisourceBergen's larger contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) 3 ml vials, with a ceiling value of $18,294.14. This competitively awarded, firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $3,759.96. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 27, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a small-value transaction typical of the company's regular medical supply deliveries...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) pharmaceutical product with a contract ceiling value of $6,541.29. This non-competitive, firm fixed price delivery order is expected to be completed by July 17, 2025, with performance at the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen Drug Corp's ongoing pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 7, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL injectable medication. The contract, valued at $17,708.07, represents a firm fixed price delivery order with an ultimate completion date of July 8, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation. This...
- The Defense Logistics Agency awarded a $13,908.48 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on July 22, 2025, with completion scheduled for July 23, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $18,687.41 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a contract ceiling value of $10,135.84. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 5, 2025. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials, with a contract ceiling value of $5,243.63. This firm fixed-price delivery order, which has an ultimate completion date of July 25, 2025, will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award utilized no set-aside designation and was competitively awarded through...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLFA4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) injectable medication with a ceiling value of $5,732.77. This is a firm fixed-price delivery order without a set-aside designation, reflecting a competitively awarded contract through open competition. The product will be delivered to the Conshohocken, Pennsylvania location, with an ultimate completion date of July 21, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order represents routine pharmaceutical procurement supporting federal military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for the Defense Logistics Agency's medical supply chain and holds extensive contract authority to supply brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a prime contractor under the DLA's comprehensive pharmaceutical support vehicle, the company fulfills medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The relatively brief performance window and specific product specification indicate this delivery order addresses immediate operational requirements within the larger pharmaceutical procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.7k | 7/18/25 |